SCHEMBL1933219

SCHEMBL1933219

CC1(C)CC(C(N)=O)C(C)(C)N1O

nearest known ligand 0.48

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ALOX15 P16050 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13225974 1.00 GAA (0.48) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL13225973 1.00 GAA (0.48) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL4397787 0.81 GAA (0.50) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL13225976 0.81 GAA (0.50) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL697858 0.81 GAA (0.50) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL9715915 0.81 GAA (0.50) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL51127 0.79 KMT2A (0.31) GAAL3MBTL1KMT2A
SCHEMBL8599636 0.79 GAA (0.48) GAAL3MBTL1KDM4EALDH1A1ALOX15
SCHEMBL12539711 0.79 KMT2A (0.31) GAAL3MBTL1KMT2A
SCHEMBL1231230 0.78 GAA (0.47) GAAL3MBTL1KDM4EALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4627345-A1 MEASUREMENT OF REACTIVE OXYGEN SPECIES TO ASSESS RED BLOOD CELL QUALITY University Of Maryland, Baltimore (US) 2025-10-08 EP claimed
US-20250298040-A1 MEASUREMENT OF REACTIVE OXYGEN SPECIES TO ASSESS RED BLOOD CELL QUALITY UNIVERSITY OF MARYLAND, BALTIMORE 2025-09-25 US claimed
WO-2024119059-A1 MEASUREMENT OF REACTIVE OXYGEN SPECIES TO ASSESS RED BLOOD CELL QUALITY UNIVERSITY OF MARYLAND, BALTIMORE (US) 2024-06-06 WO claimed
US-20230149442-A1 Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel and Uses Therefor UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-05-18 US claimed
EP-4100010-A1 COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO AND/OR RESPIRATORY DEPRESSION Case Western Reserve University (US) 2022-12-14 EP claimed
US-20220387407-A1 COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO AND/OR RESPIRATORY DEPRESSION UNIV CASE WESTERN RESERVE (US) 2022-12-08 US claimed
WO-2022251679-A1 NITROXIDE RADICALS FOR USE AS ANTIVIRAL TREATMENT FOR CORONAVIRUS INFECTION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-12-01 WO claimed
WO-2021159077-A1 COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO AND/OR RESPIRATORY DEPRESSION CASE WESTERN RESERVE UNIVERSITY (US) 2021-08-12 WO claimed
CN-107847484-B Nitroxide free radicals for the treatment of respiratory diseases 耶路撒冷希伯来大学伊森姆研究发展公司 2021-07-06 CN claimed
EP-3273956-B1 NITROXIDE RADICALS FOR THE TREATMENT OF DISEASES OF THE RESPIRATORY TRACT YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIV OF JERUSALEM LTD (IL) 2020-05-06 EP claimed
WO-2008103613-A2 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE OTHERA HOLDING, INC. (US) 2008-08-28 WO claimed
EP-1912561-A2 METHOD FOR DETERMINING REDOX STATUS OF A TISSUE Government of the United States of America, Represented by the Secretary, Department of Health and Human Services (US) 2008-04-23 EP claimed
WO-2007021847-A2 METHOD FOR DETERMINING REDOX STATUS OF A TISSUE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2007-02-22 WO claimed
WO-1998055684-A1 MULTI-COMPONENT SYSTEM FOR MODIFYING, DECOMPOSING OR BLEACHING LIGNIN, MATERIALS CONTAINING LIGNIN OR SIMILAR SUBSTANCES AND METHODS FOR PRODUCING THE SAME Consortium für elektrochemische Industrie GmbH (DE) 1998-12-10 WO claimed
US-5773635-A ALDOL CONDENSATION; IN PRESENCE OF OXYGEN OR NITRIC OXIDE BASF AKTIENGESELLSCHAFT (DE) 1998-06-30 US claimed
EP-0691329-B1 Process for the preparation of polyencarbonyl compounds with high content of the all E-isomer and their acetals or ketales BASF AG (DE) 1997-10-29 EP claimed
US-5610249-A FREE RADICAL CATALYST, ORGANIC PHOSPHORUS COMPOUND KANSAI PAINT CO., LTD. (JP) 1997-03-11 US claimed
EP-0691329-A1 Process for the preparation of polyencarbonyl compounds with high content of the all E-isomer and their acetals or ketales BASF AKTIENGESELLSCHAFT (DE) 1996-01-10 EP claimed
US-5401874-A Nitroxide free radical catalysts for oxidation of alkoxy alkanols SHELL OIL COMPANY (US) 1995-03-28 US claimed
US-3993131-A Tracing flow of petroleum in underground reservoirs CITIES SERVICE COMPANY (US) 1976-11-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149442-A1 Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel and Uses Therefor GPX4, GPX1, GSR GAA 2884/4885L3MBTL1 861/4885KDM4E 4596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.